Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses
- Resource Type
- Article
- Source
- In
Journal of Clinical Epidemiology June 2021 134:95-102 - Subject
- Language
- ISSN
- 0895-4356